1. Xiong, Ying, Wang, Lan, Deng, Weiwei, Wang, Junzhi, Shi, Taiping. 2013. Human TTC5, a novel tetratricopeptide repeat domain containing gene, activates p53 and inhibits AP-1 pathway. In Molecular biology reports, 40, 6183-8. doi:10.1007/s11033-013-2729-6. https://pubmed.ncbi.nlm.nih.gov/24091941/
2. Musante, Luciana, Faletra, Flavio, Meier, Kolja, Costa, Paola, Carrozzi, Marco. 2022. TTC5 syndrome: Clinical and molecular spectrum of a severe and recognizable condition. In American journal of medical genetics. Part A, 188, 2652-2665. doi:10.1002/ajmg.a.62852. https://pubmed.ncbi.nlm.nih.gov/35670379/
3. Rasheed, Arisha, Gumus, Evren, Zaki, Maha, Naz, Sadaf, Schaffer, Ashleigh. 2020. Bi-allelic TTC5 variants cause delayed developmental milestones and intellectual disability. In Journal of medical genetics, 58, 237-246. doi:10.1136/jmedgenet-2020-106849. https://pubmed.ncbi.nlm.nih.gov/32439809/
4. Davies, Laura, Paraskevopoulou, Elissavet, Sadeq, Malihah, Demonacos, Constantinos, Krstic-Demonacos, Marija. 2010. Regulation of glucocorticoid receptor activity by a stress responsive transcriptional cofactor. In Molecular endocrinology (Baltimore, Md.), 25, 58-71. doi:10.1210/me.2010-0212. https://pubmed.ncbi.nlm.nih.gov/21147850/
5. Batiuk, Alina, Höpfler, Markus, Almeida, Ana C, Lin, Zhewang, Gasic, Ivana. 2024. Soluble αβ-tubulins reversibly sequester TTC5 to regulate tubulin mRNA decay. In Nature communications, 15, 9963. doi:10.1038/s41467-024-54036-0. https://pubmed.ncbi.nlm.nih.gov/39551769/
6. Lynch, J T, Somerville, T D D, Spencer, G J, Huang, X, Somervaille, T C P. 2013. TTC5 is required to prevent apoptosis of acute myeloid leukemia stem cells. In Cell death & disease, 4, e573. doi:10.1038/cddis.2013.107. https://pubmed.ncbi.nlm.nih.gov/23559008/
智鼠故事 
